John P. Saharek Harrow Health, Inc. (HROW) insider trading activity

John P. Saharek is CEO & President, ImprimisRx of HARROW HEALTH, INC.. Currently has a direct ownership of 467,388 shares of HROW, which is worth approximately $11.4 Million. The most recent transaction as insider was on Apr 07, 2025, when has been sold 109,475 shares (Common Stock) at a price of $23.09 per share, resulting in proceeds of $2,527,777. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 467K

55.97% 3M change

83.43% 12M change

Total Value Held $11.4 Million

JOHN P. SAHAREK Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 07 2025	SELL Payment of exercise price or tax liability	$2,527,777 $23.09 p/Share	109,475 Reduced 18.98%	467,388 Common Stock
Apr 03 2025	BUY Exercise of conversion of derivative security	-	277,200 Added 32.46%	576,863 Common Stock
Sep 11 2024	SELL Payment of exercise price or tax liability	$1,867,441 $41.37 p/Share	45,140 Reduced 13.09%	299,663 Common Stock
Sep 11 2024	BUY Exercise of conversion of derivative security	$663,300 $7.37 p/Share	90,000 Added 20.7%	344,803 Common Stock
Mar 01 2024	BUY Exercise of conversion of derivative security	$43,750 $8.75 p/Share	5,000 Added 1.92%	254,803 Common Stock
Feb 20 2024	SELL Exercise of conversion of derivative security	$134,612 $10.67 p/Share	12,616 Reduced 4.81%	249,803 Common Stock
Feb 20 2024	BUY Exercise of conversion of derivative security	$320,100 $10.67 p/Share	30,000 Added 10.26%	262,419 Common Stock
Nov 10 2023	SELL Payment of exercise price or tax liability	$125,451 $12.83 p/Share	9,778 Reduced 4.04%	232,419 Common Stock
Nov 10 2023	BUY Exercise of conversion of derivative security	-	20,000 Added 7.63%	242,197 Common Stock
Jul 18 2023	SELL Payment of exercise price or tax liability	$1,988,528 $18.23 p/Share	109,080 Reduced 32.93%	222,197 Common Stock
Jul 18 2023	BUY Exercise of conversion of derivative security	-	277,200 Added 45.56%	331,277 Common Stock
Feb 19 2022	SELL Payment of exercise price or tax liability	$204,014 $7.87 p/Share	25,923 Reduced 32.4%	54,077 Common Stock
Feb 19 2022	BUY Exercise of conversion of derivative security	-	50,000 Added 38.46%	80,000 Common Stock

JPS

John P. Saharek

CEO & President, ImprimisRx

Nashville, TN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HROW shares.

Notify only if

Value

Insider Trading

Get notified when an Harrow Health, Inc. insider buys or sells HROW shares.

Notify only if

Operation

Value

Type

News

Receive news related to HARROW HEALTH, INC.

Track Activities on HROW

Account